Quest Diagnostics Incorporated (DGX)
NYSE: DGX · Real-Time Price · USD
163.59
-0.30 (-0.18%)
Nov 22, 2024, 4:00 PM EST - Market closed
Quest Diagnostics Stock Forecast
Stock Price Forecast
The 13 analysts with 12-month price forecasts for Quest Diagnostics stock have an average target of 163.38, with a low estimate of 135 and a high estimate of 185. The average target predicts a decrease of -0.13% from the current stock price of 163.59.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for DGX stock from 13 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 4 | 4 | 4 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 2 | 2 |
| Hold | 9 | 9 | 9 | 9 | 8 | 8 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 13 | 13 | 13 | 13 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Hold Maintains $150 → $165 | Hold | Maintains | $150 → $165 | +0.86% | Oct 28, 2024 |
| Mizuho | Mizuho | Buy Maintains $160 → $174 | Buy | Maintains | $160 → $174 | +6.36% | Oct 24, 2024 |
| UBS | UBS | Hold Maintains $165 → $166 | Hold | Maintains | $165 → $166 | +1.47% | Oct 23, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $165 → $185 | Strong Buy | Maintains | $165 → $185 | +13.09% | Oct 23, 2024 |
| Barclays | Barclays | Hold Maintains $154 → $168 | Hold | Maintains | $154 → $168 | +2.70% | Oct 23, 2024 |
Financial Forecast
Revenue This Year
9.93B
from 9.25B
Increased by 7.33%
Revenue Next Year
10.79B
from 9.93B
Increased by 8.69%
EPS This Year
8.99
from 7.49
Increased by 20.07%
EPS Next Year
9.85
from 8.99
Increased by 9.58%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 10.4B | 11.5B | 12.0B | ||
| Avg | 9.9B | 10.8B | 11.2B | ||
| Low | 9.6B | 9.9B | 10.1B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 12.4% | 15.4% | 10.8% | ||
| Avg | 7.3% | 8.7% | 3.8% | ||
| Low | 3.8% | -0.1% | -6.7% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 9.39 | 10.72 | 11.98 | ||
| Avg | 8.99 | 9.85 | 10.76 | ||
| Low | 8.68 | 9.46 | 10.09 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 25.3% | 19.2% | 21.6% | ||
| Avg | 20.1% | 9.6% | 9.2% | ||
| Low | 15.9% | 5.2% | 2.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.